BRAF and neoplasm: MSI analysis is not recommended as it may be less sensitive than IHC in ECs especially for the detection of MSH6 deficiency [40, 41], and BRAF c.1799T>A variants are rare and do not discriminate between LS and sporadic MMR deficient tumours [42].